vs
爱德华生命科学（EW）与Martin Marietta Materials（MLM）财务数据对比。点击上方公司名可切换其他公司
爱德华生命科学的季度营收约是Martin Marietta Materials的1.2倍（$1.6B vs $1.4B），Martin Marietta Materials净利率更高（111.1% vs 23.1%，领先88.0%），Martin Marietta Materials同比增速更快（17.0% vs 16.7%），过去两年爱德华生命科学的营收复合增速更高（9.7% vs -12.1%）
爱德华生命科学是总部位于美国加利福尼亚州尔湾的医疗科技企业，专注于人工心脏瓣膜及血流动力学监测领域，其研发的Sapien经导管主动脉心脏瓣膜采用牛组织材质，搭配球囊扩张式钴铬合金支架，可通过导管完成植入。
马丁·玛丽埃塔材料公司是美国大型集料及重型建筑材料供应商，业务覆盖美国26个州、加拿大及加勒比地区，主要为道路、人行道、地基等各类基建项目提供所需原材料。
EW vs MLM — 直观对比
营收规模更大
EW
是对方的1.2倍
$1.4B
营收增速更快
MLM
高出0.3%
16.7%
净利率更高
MLM
高出88.0%
23.1%
两年增速更快
EW
近两年复合增速
-12.1%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.6B | $1.4B |
| 净利润 | $380.7M | $1.5B |
| 毛利率 | 78.0% | 22.8% |
| 营业利润率 | 1.8% | 11.9% |
| 净利率 | 23.1% | 111.1% |
| 营收同比 | 16.7% | 17.0% |
| 净利润同比 | 6.8% | — |
| 每股收益（稀释后） | $0.66 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EWMLM
| Q1 26 | $1.6B | $1.4B | ||
| Q4 25 | $1.6B | $1.1B | ||
| Q3 25 | $1.6B | $1.8B | ||
| Q2 25 | $1.5B | $1.8B | ||
| Q1 25 | $1.4B | $1.4B | ||
| Q4 24 | $1.4B | $1.6B | ||
| Q3 24 | $1.4B | $1.9B | ||
| Q2 24 | $1.4B | $1.8B |
净利润EWMLM
| Q1 26 | $380.7M | $1.5B | ||
| Q4 25 | $91.2M | $279.0M | ||
| Q3 25 | $291.1M | $414.0M | ||
| Q2 25 | $333.2M | $328.0M | ||
| Q1 25 | $358.0M | $116.0M | ||
| Q4 24 | $385.6M | $293.0M | ||
| Q3 24 | $3.1B | $363.0M | ||
| Q2 24 | $366.3M | $294.0M |
毛利率EWMLM
| Q1 26 | 78.0% | 22.8% | ||
| Q4 25 | 78.1% | 35.0% | ||
| Q3 25 | 77.8% | 33.1% | ||
| Q2 25 | 77.5% | 30.0% | ||
| Q1 25 | 78.7% | 24.8% | ||
| Q4 24 | 78.9% | 30.0% | ||
| Q3 24 | 80.6% | 31.7% | ||
| Q2 24 | 79.9% | 29.3% |
营业利润率EWMLM
| Q1 26 | 1.8% | 11.9% | ||
| Q4 25 | 9.6% | 24.6% | ||
| Q3 25 | 19.8% | 27.4% | ||
| Q2 25 | 26.8% | 25.3% | ||
| Q1 25 | 27.9% | 14.3% | ||
| Q4 24 | 22.6% | 24.4% | ||
| Q3 24 | 25.9% | 25.9% | ||
| Q2 24 | 26.8% | 22.6% |
净利率EWMLM
| Q1 26 | 23.1% | 111.1% | ||
| Q4 25 | 5.8% | 24.5% | ||
| Q3 25 | 18.7% | 22.4% | ||
| Q2 25 | 21.7% | 18.1% | ||
| Q1 25 | 25.3% | 8.6% | ||
| Q4 24 | 27.8% | 18.0% | ||
| Q3 24 | 226.7% | 19.2% | ||
| Q2 24 | 26.7% | 16.7% |
每股收益（稀释后）EWMLM
| Q1 26 | $0.66 | — | ||
| Q4 25 | $0.16 | $4.59 | ||
| Q3 25 | $0.50 | $6.85 | ||
| Q2 25 | $0.56 | $5.43 | ||
| Q1 25 | $0.61 | $1.90 | ||
| Q4 24 | $0.65 | $4.87 | ||
| Q3 24 | $5.13 | $5.91 | ||
| Q2 24 | $0.61 | $4.76 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $273.0M |
| 总债务越低越好 | — | $0 |
| 股东权益账面价值 | — | $11.3B |
| 总资产 | — | $20.5B |
| 负债/权益比越低杠杆越低 | — | 0.00× |
8季度趋势，按日历期对齐
现金及短期投资EWMLM
| Q1 26 | — | $273.0M | ||
| Q4 25 | $4.2B | $67.0M | ||
| Q3 25 | $3.8B | $57.0M | ||
| Q2 25 | $4.1B | $225.0M | ||
| Q1 25 | $3.9B | $101.0M | ||
| Q4 24 | $4.0B | $670.0M | ||
| Q3 24 | $4.4B | $52.0M | ||
| Q2 24 | $2.0B | $109.0M |
总债务EWMLM
| Q1 26 | — | $0 | ||
| Q4 25 | — | $5.3B | ||
| Q3 25 | — | $5.5B | ||
| Q2 25 | — | $5.4B | ||
| Q1 25 | — | $5.4B | ||
| Q4 24 | — | $5.4B | ||
| Q3 24 | — | $4.0B | ||
| Q2 24 | — | $4.3B |
股东权益EWMLM
| Q1 26 | — | $11.3B | ||
| Q4 25 | $10.3B | $10.0B | ||
| Q3 25 | $10.2B | $9.7B | ||
| Q2 25 | $10.5B | $9.4B | ||
| Q1 25 | $10.1B | $9.1B | ||
| Q4 24 | $10.0B | $9.5B | ||
| Q3 24 | $9.5B | $9.2B | ||
| Q2 24 | $7.4B | $8.8B |
总资产EWMLM
| Q1 26 | — | $20.5B | ||
| Q4 25 | $13.7B | $18.7B | ||
| Q3 25 | $13.3B | $18.7B | ||
| Q2 25 | $13.5B | $18.1B | ||
| Q1 25 | $13.0B | $17.7B | ||
| Q4 24 | $13.1B | $18.2B | ||
| Q3 24 | $13.0B | $16.5B | ||
| Q2 24 | $10.1B | $16.3B |
负债/权益比EWMLM
| Q1 26 | — | 0.00× | ||
| Q4 25 | — | 0.53× | ||
| Q3 25 | — | 0.57× | ||
| Q2 25 | — | 0.58× | ||
| Q1 25 | — | 0.60× | ||
| Q4 24 | — | 0.57× | ||
| Q3 24 | — | 0.44× | ||
| Q2 24 | — | 0.49× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $227.0M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | 40.4% |
| 现金转化率经营现金流/净利润 | — | 0.15× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流EWMLM
| Q1 26 | — | $227.0M | ||
| Q4 25 | $450.9M | $629.0M | ||
| Q3 25 | $573.7M | $551.0M | ||
| Q2 25 | $290.2M | $387.0M | ||
| Q1 25 | $280.4M | $218.0M | ||
| Q4 24 | $-127.5M | $686.0M | ||
| Q3 24 | $351.8M | $600.0M | ||
| Q2 24 | $371.5M | $1.0M |
自由现金流EWMLM
| Q1 26 | — | — | ||
| Q4 25 | $353.5M | $424.0M | ||
| Q3 25 | $516.2M | $361.0M | ||
| Q2 25 | $240.9M | $208.0M | ||
| Q1 25 | $224.4M | $-15.0M | ||
| Q4 24 | $-177.3M | $453.0M | ||
| Q3 24 | $299.9M | $317.0M | ||
| Q2 24 | $286.1M | $-138.0M |
自由现金流率EWMLM
| Q1 26 | — | — | ||
| Q4 25 | 22.5% | 37.2% | ||
| Q3 25 | 33.2% | 19.6% | ||
| Q2 25 | 15.7% | 11.5% | ||
| Q1 25 | 15.9% | -1.1% | ||
| Q4 24 | -12.8% | 27.8% | ||
| Q3 24 | 22.1% | 16.8% | ||
| Q2 24 | 20.9% | -7.8% |
资本支出强度EWMLM
| Q1 26 | — | 40.4% | ||
| Q4 25 | 6.2% | 18.0% | ||
| Q3 25 | 3.7% | 10.3% | ||
| Q2 25 | 3.2% | 9.9% | ||
| Q1 25 | 4.0% | 17.2% | ||
| Q4 24 | 3.6% | 14.3% | ||
| Q3 24 | 3.8% | 15.0% | ||
| Q2 24 | 6.2% | 7.9% |
现金转化率EWMLM
| Q1 26 | — | 0.15× | ||
| Q4 25 | 4.94× | 2.25× | ||
| Q3 25 | 1.97× | 1.33× | ||
| Q2 25 | 0.87× | 1.18× | ||
| Q1 25 | 0.78× | 1.88× | ||
| Q4 24 | -0.33× | 2.34× | ||
| Q3 24 | 0.11× | 1.65× | ||
| Q2 24 | 1.01× | 0.00× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
